If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Long-acting GLP-1 Fc-fusion research reference (Trulicity analog)
Overview
Dulaglutide (brand name Trulicity) is a long-acting GLP-1 receptor agonist fusion protein developed by Eli Lilly. It was approved by the FDA in September 2014 for glycemic control in type 2 diabetes, and gained a second approval in February 2020 for reducing major adverse cardiovascular events in type 2 diabetes patients with established cardiovascular disease or multiple cardiovascular risk factors. Vialdyne releases Dulaglutide as a lyophilized peptide against a ≥95% purity specification (SEC/RP-HPLC), supplied with a batch-specific Certificate of Analysis covering RP-HPLC purity, mass-spec identity and appearance; water content is available on request and listed on the COA when tested. Lots are released only after the COA is on file.
Applications & buyer fit
Most buyers in this category are 503A and 503B compounding pharmacies fulfilling metabolic and weight-management protocols, plus research labs investigating GLP-1 / GIP / GCG receptor pharmacology. The procurement decision usually hinges on three things: documented purity at scale, a regulatory team that can respond on destination-market questions in writing, and the ability to supply consistent counter-ion form (acetate by default) across recurring orders.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Supplied as a documented active in acetate counter-ion form by default; the buyer verifies current scheduling and compounding eligibility for the destination market.
Primary buyer fit: academic and contract research laboratories.
Specifications
Batch COAs and test reports
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Batch COADulaglutide 5 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Batch COADulaglutide 10 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Independent test fails? Full refund. How it works
Browse all COAs and reportsRegulatory note
Research-use-only reference material; not for human or veterinary use.
Selected literature
Frequently asked questions
Dulaglutide ships as white lyophilized powder with a batch-specific Certificate of Analysis reporting RP-HPLC purity (specification ≥95% (SEC/RP-HPLC)), mass-spec identity, and appearance. Recommended storage: -20°C; reconstituted 2–8°C. Supplied strictly as a research reference material — not for human or veterinary use.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
GLP-1 receptor agonist
Nasal spray listed
GIP / GLP-1 dual receptor agonist
Nasal spray listed
GLP-1 receptor agonist (long-acting)
Nasal spray listed